Standard BioTools (LAB) Proxy filing summary

Executive summary

• Annual meeting scheduled for June 17, 2026, with virtual participation available to shareholders.

• Shareholders are encouraged to review proxy materials and annual report before voting.

Voting matters and shareholder proposals

• Election of three Class I directors: Michael Egholm, Ph.D., Thomas Carey, and Eli Casdin.

• Advisory vote on executive compensation (say-on-pay) for named executive officers.

• Ratification of PricewaterhouseCoopers LLP as independent auditor for fiscal year ending December 31, 2026.

• Approval of the 2026 Equity Incentive Plan.

• Amendment to the 2017 Employee Stock Purchase Plan to increase available shares by 1,200,000.

Board of directors and corporate governance

• Board recommends voting in favor of all proposals, including director nominees and compensation plans.